Hepatica Merchants Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 07-12-2024
- Paid Up Capital ₹ 0.50 M
as on 07-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -76.29%
(FY 2022)
- Profit 101.88%
(FY 2022)
- Ebitda 96.80%
(FY 2022)
- Net Worth 0.05%
(FY 2022)
- Total Assets -0.00%
(FY 2022)
About Hepatica Merchants
The Corporate was formerly known as Hepatica Merchants Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Suraj Bagree, Andip Samanta, and Pratima Hait serve as directors at the Company.
- CIN/LLPIN
U51909WB2011PLC157433
- Company No.
157433
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hepatica Merchants?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Bagree  | Director | 09-Aug-2021 | Current |
| Andip Samanta | Director | 08-Jan-2018 | Current |
| Pratima Hait | Director | 08-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Hepatica Merchants.
Hepatica Merchants Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 76.29% decrease. The company also saw a substantial improvement in profitability, with a 101.88% increase in profit. The company's net worth moved up by a moderate rise of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hepatica Merchants?
In 2017, Hepatica Merchants had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Daisy Commosales LimitedActive 14 years 9 months
Suraj Bagree, Andip Samanta and 1 more are mutual person
- Festino Dealtrade LimitedActive 14 years 9 months
Suraj Bagree, Andip Samanta and 1 more are mutual person
- Oscar Retailers LimitedActive 13 years 11 months
Suraj Bagree, Andip Samanta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hepatica Merchants?
Unlock and access historical data on people associated with Hepatica Merchants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hepatica Merchants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hepatica Merchants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
